Oropharyngeal Cancer Global Clinical Trials Review, H1, 2012

Oropharyngeal Cancer Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Oropharyngeal Cancer Global Clinical Trials Review, H1, 2012" provides data on the Oropharyngeal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Oropharyngeal Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Oropharyngeal Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Contents

Introduction
Oropharyngeal Cancer
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Oropharyngeal Cancer
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Oropharyngeal Cancer Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Endo Pharmaceuticals Inc.
Clinical Trial Overview of Endo Pharmaceuticals Inc.
Pharmacyclics, Inc.
Clinical Trial Overview of Pharmacyclics, Inc.
Vical Incorporated
Clinical Trial Overview of Vical Incorporated
Clinical Trial Overview of Top Universities / Institutes / Hospitals
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Clinical Trial Overview of Ohio State University Comprehensive Cancer Center
Stanford University
Clinical Trial Overview of Stanford University
Radiation Therapy Oncology Group
Clinical Trial Overview of Radiation Therapy Oncology Group
Mount Sinai School of Medicine
Clinical Trial Overview of Mount Sinai School of Medicine
Shanghai Jiao Tong University
Clinical Trial Overview of Shanghai Jiao Tong University
Southeastern Medical Oncology Center
Clinical Trial Overview of Southeastern Medical Oncology Center
Institut Gustave Roussy
Clinical Trial Overview of Institut Gustave Roussy
Abramson Cancer Center
Clinical Trial Overview of Abramson Cancer Center
European Organization for Research and Treatment of Cancer
Clinical Trial Overview of European Organization for Research and Treatment of Cancer
Southwest Oncology Group
Clinical Trial Overview of Southwest Oncology Group
Groupe Oncologie Radiotherapie Tete et Cou
Clinical Trial Overview of Groupe Oncologie Radiotherapie Tete et Cou
Johannes Gutenberg University Mainz
Clinical Trial Overview of Johannes Gutenberg University Mainz
Wake Forest University
Clinical Trial Overview of Wake Forest University
FUDAN University
Clinical Trial Overview of FUDAN University
University of Zurich
Clinical Trial Overview of University of Zurich
VCU Massey Cancer Center
Clinical Trial Overview of VCU Massey Cancer Center
Samsung Medical Center
Clinical Trial Overview of Samsung Medical Center
University of Michigan Comprehensive Cancer Center
Clinical Trial Overview of University of Michigan Comprehensive Cancer Center
Roswell Park Cancer Institute
Clinical Trial Overview of Roswell Park Cancer Institute
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Oropharyngeal Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Oropharyngeal Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Oropharyngeal Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials, BRIC Countries, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials, G7 Countries, 2012*
Oropharyngeal Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials, E7 Countries, 2012*
Oropharyngeal Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Oropharyngeal Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012*
Oropharyngeal Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
Oropharyngeal Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Oropharyngeal Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012*
Oropharyngeal Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Oropharyngeal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Endo Pharmaceuticals Inc., 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmacyclics, Inc., 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Vical Incorporated, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University Comprehensive Cancer Center, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mount Sinai School of Medicine, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai Jiao Tong University, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southeastern Medical Oncology Center, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut Gustave Roussy, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Abramson Cancer Center, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe Oncologie Radiotherapie Tete et Cou, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Johannes Gutenberg University Mainz, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by VCU Massey Cancer Center, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012*

LIST OF FIGURES

Oropharyngeal Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
Oropharyngeal Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Oropharyngeal Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012*
Oropharyngeal Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials, E7 Countries (%), 2012*
Oropharyngeal Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Oropharyngeal Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
Oropharyngeal Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
Oropharyngeal Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Oropharyngeal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Oropharyngeal Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
GlobalData Methodology Skip to top